Table 2.
Payment Model | Providers | Incentivises | Literature |
---|---|---|---|
Combination of contract capitation payment and fee for service | General practitioner |
Positive Fewer referrals Adequate provision of care (no under- or overtreatment) Preventive care Negative Collaboration not explicitly addressed |
[20,47,48,49] |
Fee for service (FFS) | Physiotherapist, exercise therapist, speech therapist, dietician, and district nursing |
Positive High productivity Transparency of the delivered care Negative Overprovision Unnecessary readmissions and diagnostics Quality of care not explicitly addressed Fragmentation of care Preventive care not stimulated |
[50,51,52,53] |
Per time period | Salary paid health care providers |
Positive Cost-conscious behaviour Negative Undertreatment Selection of patients Low productivity which could result in longer waiting lists Quality of care not explicitly addressed Unnecessary referrals |
[54,55,56] |
Per episode (chronic care) | The SDMPs for chronic diseases in primary care |
Positive Integrated care (coordination and continuity) Cost-conscious behaviour High quality of care Efficient care Negative Risk selection ‘Over-bundling’ * Double billing Unnecessary referrals Undertreatment within the bundle |
[14,50,57,58,59,60] |
Per episode (1. DTCs in specialist care, 2. Per patient profile and time, and 3. Per treatment activity and time) |
|
Positive Less fragmentation of care Efficiency Negative Strategic declaration behaviour Overprovision Upcoding |
[61,62,63] |
Contract capitation in combination with a patient co-payment (€19 per month) | Social care |
Positive Wide access because of the low co-payment Flexibility to tailor help to personal circumstances Negative Underuse because of accumulating co-payments |
[64,65] |
Pay for performance | Alternative payment model |
Positive Quality of care explicitly addressed Transparency of care Positive spill-over effects ** Negative Negative spill-over effects ** Risk selection Gaming behaviour No incentive if threshold is met Providers held accountable for outcomes they may not be able to influence |
[37,40,41,66,67,68,69,70] |
Shared savings model | Alternative payment model |
Positive Cost-conscious behaviour Integrated care (coordination and continuity) Preventive care Quality of care (implicitly and explicitly) Negative Undertreatment To drive the expenditures of the benchmark |
[13,14,15,42,43,71,72,73,74] |
(Sub)population—based bundled payment | Alternative payment model |
Positive Integrated care (coordination and continuity) Quality of care Cost-conscious behaviour Preventive care Negative High risk for the contracting entity Reduction of necessary care in the bundle Less freedom of choice Risk selection |
[16,17,18,45] |
Note: DMPs = disease management programmes, DTCs = disease-treatment combinations. * Over-bundling refers to the incentive to broaden the diagnoses, as to increase the target population for which a provider receives a bundled payment (e.g., including pre-diabetes patients at risk of developing diabetes in the bundled payment of diabetes patients). ** Positive spill-over effects occur when non-measured outcomes improve as well, as a consequence of the extra attention for the measured outcomes. Negative spill-over effects occur when a focus on measured outcomes leads to non-measured outcomes being neglected and deteriorating.